Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 1/20 | 0.52 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.47 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.47 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.47 |
| ▸ | LDHA | P00338 | 1/20 | 0.47 |
| ▸ | LDHB | P07195 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.46 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL670158 | 0.90 | BCL2 (0.57) | BCL2BCL2L1PTPN1PTPN2PTPN6 | |
| SCHEMBL1904809 | 0.89 | AMY1A (0.58) | BCL2BCL2L1PTPN1PTPN2PTPN6 | |
| SCHEMBL545616 | 0.87 | AMY1A (0.52) | EGFRERBB2AMY1AALOX5 | |
| SCHEMBL31146662 | 0.85 | SHBG (0.61) | BCL2BCL2L1PTPN1PTPN2PTPN6 | |
| SCHEMBL8680810 | 0.85 | EGFR (0.49) | EGFRERBB2AMY1A | |
| SCHEMBL8990148 | 0.85 | BCL2 (0.52) | BCL2BCL2L1PTPN1PTPN2PTPN6 | |
| SCHEMBL28693854 | 0.84 | IDH1 (0.49) | EGFRERBB2AMY1A | |
| SCHEMBL31603741 | 0.84 | PTGS1 (0.47) | BCL2BCL2L1EGFRERBB2ALOX5 | |
| SCHEMBL10905506 | 0.83 | PTPN1 (0.50) | BCL2BCL2L1PTPN1PTPN2PTPN6 | |
| SCHEMBL5685298 | 0.82 | SHBG (0.57) | EGFRERBB2AMY1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115243764-B | Heterocyclic derivatives as TRMP antagonists | 奇华顿股份有限公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-118813293-A | High-density hydrocarbon fuel and preparation method thereof | 陕西煤基特种燃料研究院有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-118813292-A | High-density fuel and production method thereof | 陕西煤基特种燃料研究院有限公司 | 2024-10-22 | — | — | CN | disclosed |
| US-20230098332-A1 | HETEROCYCLIC DERIVATIVES AS TRMP8 ANTAGONISTS | GIVAUDAN SA (CH) | 2023-03-30 | — | — | US | disclosed |
| EP-4114523-A1 | HETEROCYCLIC DERIVATIVES AS TRMP8 ANTAGONISTS | Givaudan SA (CH) | 2023-01-11 | — | — | EP | disclosed |
| CN-115243764-A | Heterocyclic derivatives as TRMP8 antagonists | 奇华顿股份有限公司 | 2022-10-25 | — | — | CN | disclosed |
| US-8110589-B2 | Ectoparasiticide composition and a method for exterminating extoparasites | KYOYU AGRI CO., LTD. (JP) | 2012-02-07 | — | — | US | disclosed |
| US-20090312378-A1 | ECTOPARASITICIDE COMPOSITION AND A METHOD FOR EXTERMINATING ECTOPARASITES | YASHIMA SANGYO CO., LTD. (JP) | 2009-12-17 | — | — | US | disclosed |
| US-7202018-B2 | Silver salt photothermographic dry imaging material | KONICA CORPORATION (JP) | 2007-04-10 | — | — | US | disclosed |
| CN-1072811-C | Novel matrix resin for high-temperature stable photoimageable compositions | 科莱恩金融(BVI)有限公司 | 2001-10-10 | — | — | CN | disclosed |
| EP-0451761-B1 | Organic electronic material and electrophotographic photosensitive member containing it | CANON KK (JP) | 1996-07-03 | — | — | EP | disclosed |
| US-5176976-A | Stilbenequinones as stable charge transfer compounds | CANON KABUSHIKI KAISHA (JP) | 1993-01-05 | — | — | US | disclosed |
| EP-0451761-A1 | Organic electronic material and electrophotographic photosensitive member containing it | CANON KABUSHIKI KAISHA (JP) | 1991-10-16 | — | — | EP | disclosed |
| EP-0186255-A2 | Process for preparing benzyl substituted phenols, dibenzylphenolic compounds, and the antioxidant use of such phenols | ETHYL CORPORATION (US) | 1986-07-02 | — | — | EP | disclosed |
| US-4514577-A | ANTIOXIDANTS | ETHYL CORPORATION (US) | 1985-04-30 | — | — | US | disclosed |
| US-3991139-A | NORBORNENE DERIVATIVES, PHENOLS, ESTER THIOETHERS | SHOWA DENKO KABUSHIKI KAISHA (JA) | 1976-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230098332-A1 | HETEROCYCLIC DERIVATIVES AS TRMP8 ANTAGONISTS | TRPM8, TRPM7, TRPM5 | BCL2 3046/4885BCL2L1 3362/4885PTPN1 4238/4885 |
| US-20090312378-A1 | ECTOPARASITICIDE COMPOSITION AND A METHOD FOR EXTERMINATING ECTOPARASITES | EPX, TYR, PPOX | BCL2 1991/4885BCL2L1 3079/4885PTPN1 2086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.